Automated analysis of free speech predicts psychosis onset in high-risk youths G Bedi, F Carrillo, GA Cecchi, DF Slezak, M Sigman, NB Mota, S Ribeiro, ... npj Schizophrenia 1 (1), 1-7, 2015 | 584 | 2015 |
Prediction of psychosis across protocols and risk cohorts using automated language analysis CM Corcoran, F Carrillo, D Fernández‐Slezak, G Bedi, C Klim, DC Javitt, ... World Psychiatry 17 (1), 67-75, 2018 | 419 | 2018 |
Is ecstasy an “empathogen”? Effects of±3, 4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others G Bedi, D Hyman, H de Wit Biological psychiatry 68 (12), 1134-1140, 2010 | 297 | 2010 |
Incubation of cue-induced cigarette craving during abstinence in human smokers G Bedi, KL Preston, DH Epstein, SJ Heishman, GF Marrone, Y Shaham, ... Biological psychiatry 69 (7), 708-711, 2011 | 254 | 2011 |
Effects of MDMA on sociability and neural response to social threat and social reward G Bedi, KL Phan, M Angstadt, H De Wit Psychopharmacology 207, 73-83, 2009 | 237 | 2009 |
Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis M Haney, RJ Malcolm, S Babalonis, PA Nuzzo, ZD Cooper, G Bedi, ... Neuropsychopharmacology 41 (8), 1974-1982, 2016 | 210 | 2016 |
The prosocial effects of 3, 4-methylenedioxymethamphetamine (MDMA): controlled studies in humans and laboratory animals P Kamilar-Britt, G Bedi Neuroscience & Biobehavioral Reviews 57, 433-446, 2015 | 161 | 2015 |
Intimate partner violence: What are the impacts on children? G Bedi, C Goddard Australian Psychologist 42 (1), 66-77, 2007 | 158 | 2007 |
Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability ZD Cooper, G Bedi, D Ramesh, R Balter, SD Comer, M Haney Neuropsychopharmacology 43 (10), 2046-2055, 2018 | 153 | 2018 |
Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse M Haney, ZD Cooper, G Bedi, SK Vosburg, SD Comer, RW Foltin Neuropsychopharmacology 38 (8), 1557-1565, 2013 | 138 | 2013 |
Optimism, coping style and emotional well‐being in cardiac patients G Bedi, SL Brown British journal of health psychology 10 (1), 57-70, 2005 | 123 | 2005 |
A window into the intoxicated mind? Speech as an index of psychoactive drug effects G Bedi, GA Cecchi, DF Slezak, F Carrillo, M Sigman, H De Wit Neuropsychopharmacology 39 (10), 2340-2348, 2014 | 116 | 2014 |
Subjective, cognitive and cardiovascular dose‐effect profile of nabilone and dronabinol in marijuana smokers G Bedi, ZD Cooper, M Haney Addiction biology 18 (5), 872-881, 2013 | 110 | 2013 |
Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status M Haney, G Bedi, ZD Cooper, A Glass, SK Vosburg, SD Comer, RW Foltin Biological psychiatry 73 (3), 242-248, 2013 | 107 | 2013 |
Intimate partner violence and child abuse: a child‐centred perspective C Goddard, G Bedi Child Abuse Review: Journal of the British Association for the Study and …, 2010 | 105 | 2010 |
Gender inequality in awarded research grants G Bedi, NT Van Dam, M Munafo The Lancet 380 (9840), 474, 2012 | 99 | 2012 |
Efficacy and tolerability of high-dose dronabinol maintenance in HIV-positive marijuana smokers: a controlled laboratory study G Bedi, RW Foltin, EW Gunderson, J Rabkin, CL Hart, SD Comer, ... Psychopharmacology 212, 675-686, 2010 | 91 | 2010 |
Impact of social status and antidepressant treatment on neurogenesis in the baboon hippocampus MV Wu, JL Shamy, G Bedi, CWJ Choi, MM Wall, V Arango, M Boldrini, ... Neuropsychopharmacology 39 (8), 1861-1871, 2014 | 81 | 2014 |
Naltrexone maintenance decreases cannabis self-administration and subjective effects in daily cannabis smokers M Haney, D Ramesh, A Glass, M Pavlicova, G Bedi, ZD Cooper Neuropsychopharmacology 40 (11), 2489-2498, 2015 | 70 | 2015 |
Effects of delta-9-tetrahydrocannabinol on evaluation of emotional images ME Ballard, G Bedi, H de Wit Journal of psychopharmacology 26 (10), 1289-1298, 2012 | 65 | 2012 |